• Home
  • Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis.

Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis.

Author List
Li M, Sack JS, Rahma OE, Hodi FS, Zucker SD, Grover S
Publication
Cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/338181217
Publication Year
2020
PubMed ID
32888341
Publication Title
Li M, Sack JS, Rahma OE, Hodi FS, Zucker SD, Grover S. Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis. Cancer. 2020 12 01; 126(23):5088-5097.